Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis
about
Integrated therapy for HIV and cryptococcosisHIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited SettingsEfficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis.Prevalence and Hospital Management of Amphotericin B Deoxycholate-Related Toxicities during Treatment of HIV-Associated Cryptococcal Meningitis in South AfricaMolecular organization, localization and orientation of antifungal antibiotic amphotericin B in a single lipid bilayer.Prognostic implications of baseline anaemia and changes in haemoglobin concentrations with amphotericin B therapy for cryptococcal meningitisEfficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis.Addressing Antiretroviral Therapy-Associated Drug-Drug Interactions in Patients Requiring Treatment for Opportunistic Infections in Low-Income and Resource-Limited Settings.Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis.Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease.Cryptococcoma mimicking a brain tumor in an immunocompetent patient: case report of an extremely rare presentation.The war on cryptococcosis: A Review of the antifungal arsenal.Cryptococcal meningitis.Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome.Study of Azole - Resistant and Cyp51a Gene in Aspergillus Fumigatus.Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis.
P2860
Q28077707-173AA330-E692-4AAB-ADCF-3D5079527688Q28078958-48505415-2784-4B48-BB39-DE40391E0D4FQ30240770-BF52A4EE-25F9-4AE8-9281-2E20D6384D54Q36088679-51048A18-74A3-451F-BAF0-5D94B776906DQ37251023-2798E0B2-9827-4BFF-AA00-414327BDBD0BQ38854793-87658C05-64E3-4611-B871-4D8C217F197DQ40043040-4706A096-81EC-4847-86F6-2D47FBDA21DAQ40051462-52564FB6-5685-4A17-AC79-085D30615ACCQ40287344-D9D07B3B-864C-43C0-934D-9CCF24FF7693Q47561431-90BFA906-516B-4663-BABE-D78319F390B1Q47586325-82BBC396-F8F9-481C-9D02-4E9060327144Q54260674-856C90DC-BDBA-4CEF-A82A-92A3B6300391Q54368432-22B94187-413C-4C20-A8A0-9B947E9F39ADQ55229762-A35F7EA6-F648-4772-A009-1F247D7EE40DQ55404831-6D827448-5D31-4D5A-8EF5-A9E086098D47Q55488494-ABF47AAE-BE8B-4C9F-B63F-1D54EE4ED57E
P2860
Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Toxicity of Amphotericin B Deo ...... ciated Cryptococcal Meningitis
@ast
Toxicity of Amphotericin B Deo ...... ciated Cryptococcal Meningitis
@en
type
label
Toxicity of Amphotericin B Deo ...... ciated Cryptococcal Meningitis
@ast
Toxicity of Amphotericin B Deo ...... ciated Cryptococcal Meningitis
@en
prefLabel
Toxicity of Amphotericin B Deo ...... ciated Cryptococcal Meningitis
@ast
Toxicity of Amphotericin B Deo ...... ciated Cryptococcal Meningitis
@en
P2093
P2860
P50
P356
P1476
Toxicity of Amphotericin B Deo ...... ciated Cryptococcal Meningitis
@en
P2093
Angela Loyse
Annemarie E Brouwer
Arthur Jackson
Christian Bottomley
Conrad Muzoora
Douglas Wilson
Jacob Phulusa
Joseph N Jarvis
Kabanda Taseera
Mina C Hosseinipour
P2860
P304
P356
10.1128/AAC.01698-15
P407
P50
P577
2015-09-08T00:00:00Z